www.allontherapeutics.com
Click here to view a searchable, detailed profile of this and the many other life sciences organizations across the province on the LifeSciences BC directory powered by flintbox.
For a national directory of life sciences organizations, click here
Address:
506-1168 Hamilton St.
Vancouver, BC V6B 2S2
Canada
Tel: 604-736-0634
Fax: 604-736-1616
Member Sector:
Biopharmaceuticals
Allon Therapeutics Inc. is a clinical-stage biotechnology company focused on bringing to market innovative central nervous system therapies. Allon’s lead drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA). This pivotal trial is based upon statistically significant human efficacy demonstrated in amnestic mild cognitive impairment, cognitive impairment associated with schizophrenia, and positive biomarker data.
The Company is listed on the Toronto Stock Exchange (TSX:NPC) and based in Vancouver.